Clinical Trial Update: Senolytics Treatment of Interstitial Lung Disease in Common Variable Immunodeficiency [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating senolytic therapy for interstitial lung disease in people with common variable immunodeficiency; the study is currently enr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Variable Immunodeficiency
• Interstitial Lung Disease

Snippet

Sponsor: Avni Joshi | Conditions: Common Variable Immunodeficiency, Interstitial Lung Disease Due to Systemic Disease | Phase 2 | Status: ENROLLING_BY_INVITATION